The Academy of Managed Care Pharmacy (AMCP) writes to support and express concerns with specific provisions of Senate Bill 32. We strongly support the language in the Bill which allows a pharmacist to substitute an FDA approved “interchangeable biological product”.
The Academy of Managed Care Pharmacy (AMCP) writes to support and express concerns with specific provisions of Senate Bill 197. This legislation would regulate biological products and substitution of interchangeable biological products when dispensed by pharmacists.
The Academy of Managed Care Pharmacy (AMCP) writes to support and express concerns with specific provisions of Senate Bill 197. This legislation would regulate biological products and substitution of interchangeable biological products when dispensed by pharmacists.
The recommendations included in this letter are based upon consensus recommendations of an Academy of Managed Care Pharmacy (AMCP) Partnership Forum, Advancing ValueBased Contracting (VBC), held in June 2017.